Young cancer survivors face a higher risk of early heart failure: Study
Anthracyclines, a particular class of chemotherapy that breaks the DNA in cancer cells, have been reported to increase the risk of heart failure among young adult cancer survivors (between the ages of 18 and 39 at diagnosis) by 2.6 times. The first study to estimate the risk of heart failure among young adult cancer survivors treated with […]
Karobar
0
Anthracyclines, a particular class of chemotherapy that breaks the DNA in cancer cells, have been reported to increase the risk of heart failure among young adult cancer survivors (between the ages of 18 and 39 at diagnosis) by 2.6 times. The first study to estimate the risk of heart failure among young adult cancer survivors treated with […]
